scholarly journals Effects ofAdding Hydrotalcite with Different Compositional Ratios in the Pyrolysis Treatment of Brominated Plastics

2021 ◽  
Vol 12 (1) ◽  
pp. 7-11
Author(s):  
Kimi Hanazawa ◽  
◽  
Moemi Toritsuka ◽  
Naoyuki Morita ◽  
Keyword(s):  
Circular Economy ◽  
Resource Depletion ◽  
Tetrabromobisphenol A ◽  
Chemical Recycling ◽  
Composition Ratio ◽  
Halogen Compounds ◽  
Oil Residue

In recent years, chemical recycling technologies related to the pyrolysis of plastics into fuels have received increasing attention under the circular economy agenda with respect to resource depletion. Herein, a method is presented to reduce halogen compounds in the product oil derived from the pyrolysis of polystyrene with tetrabromobisphenol A. Analysis was undertaken to identify the bromine compounds present in the residue after the pyrolysis treatment. Pyrolysis was conducted in the presence of hydrotalcites as a function of the Mg and Al additive composition ratio (type 1; KW-1000 and type 2; K W-2000). The bromine compounds identified in the oil after pyrolysis at 400 °C were determined as 2-bromophenol, 4- bromophenol, 2,4-dibromophenol, 1- bromomethylbenzene, 2- bromomethylbenzene, and 3,6-dibromo-2,5-xylidine. In the absence of hydrotalcite, bromine compounds were still detected in the product oil, residue and gas, whereas the addition of KW-2000 reduced the concentration of bromine compounds in the product oil. The reduced concentration of the bromine compounds in the product oil is suggested to be related to the trapping of bromine by the added hydrotalcite during the pyrolysis of the plastic.

Type 2 Diabetes Overtakes Type 1 in Hispanic Girls

2008 ◽  
Vol 38 (15) ◽  
pp. 18
Author(s):  
SHERRY BOSCHERT
Keyword(s):  
Type 2 Diabetes

Molecular analysis of FVIII gene in severe HA patients of Costa Rica

2010 ◽  
Vol 30 (S 01) ◽  
pp. S150-S152
Author(s):  
G. Jiménez-Cruz ◽  
M. Mendez ◽  
P. Chaverri ◽  
P. Alvarado ◽  
W. Schröder ◽  
...  
Keyword(s):  
Factor Viii ◽  
Coagulation Factor ◽  
Costa Rican ◽  
Factor Viii Gene ◽  
Intron 22 Inversion ◽  
Intron 1 ◽  
Polymerase Chain ◽  
Inversion Analysis

SummaryHaemophilia A (HA) is X-chromosome linked bleeding disorders caused by deficiency of the coagulation factor VIII (FVIII). It is caused by FVIII gene intron 22 inversion (Inv22) in approximately 45% and by intron 1 inversion (Inv1) in 5% of the patients. Both inversions occur as a result of intrachromosomal recombination between homologous regions, in intron 1 or 22 and their extragenic copy located telomeric to the FVIII gene. The aim of this study was to analyze the presence of these mutations in 25 HA Costa Rican families. Patients, methods: We studied 34 HA patients and 110 unrelated obligate members and possible carriers for the presence of Inv22or Inv1. Standard analyses of the factor VIII gene were used incl. Southern blot and long-range polymerase chain reaction for inversion analysis. Results: We found altered Inv22 restriction profiles in 21 patients and 37 carriers. It was found type 1 and type 2 of the inversion of Inv22. During the screening for Inv1 among the HA patient, who were Inv22 negative, we did not found this mutation. Discussion: Our data highlight the importance of the analysis of Inv22 for their association with development of inhibitors in the HA patients and we are continuous searching of Inv1 mutation. This knowledge represents a step for genetic counseling and prevention of the inhibitor development.

Polymorphisms of the Plasminogen Activator Inhibitor- 1 Gene in Type 1 and Type 2 Diabetes, and in Patients with Diabetic Retinopathy

1994 ◽  
Vol 71 (06) ◽  
pp. 731-736 ◽  
Author(s):  
M W Mansfield ◽  
M H Stickland ◽  
A M Carter ◽  
P J Grant
Keyword(s):  
Diabetic Retinopathy ◽  
Plasminogen Activator Inhibitor ◽  
Allelic Frequency ◽  
Repeat Sequence ◽  
Dinucleotide Repeat ◽  
Plasminogen Activator Inhibitor 1 ◽  
The Difference ◽  
Pai 1

SummaryTo identify whether genotype contributes to the difference in PAI-1 levels in type 1 and type 2 diabetic subjects and whether genotype relates to the development of retinopathy, a Hind III restriction fragment length polymorphism and two dinucleotide repeat polymorphisms were studied. In 519 Caucasian diabetic subjects (192 type 1, 327 type 2) and 123 Caucasian control subjects there were no differences in the frequency of the Hind III restriction alleles (type 1 vs type 2 vs control: allele 1 0.397 vs 0.420 vs 0.448; allele 2 0.603 vs 0.580 vs 0.552) nor in the allelic frequency at either dinucleotide repeat sequence. In 86 subjects with no retinopathy at 15 years or more from diagnosis of diabetes and 190 subjects with diabetic retinopathy there was no difference in the frequency of Hind III restriction alleles (retinopathy present vs retinopathy absent: allele 1 0.400 vs 0.467; allele 2 0.600 vs 0.533) nor in the allelic frequencies at either dinucleotide repeat sequence. The results indicate that there is no or minimal influence of the PAI-1 gene on either PAI-1 levels or the development of diabetic retinopathy in patients with diabetes mellitus.

Causes of diabetic ketoacidosis: type 1 diabetes versus type 2 diabetes

2017 ◽  
Author(s):  
Marwa Omri ◽  
Rayene Ben Mohamed ◽  
Imen Rezgani ◽  
Sana Mhidhi ◽  
Aroua Temessek ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Type 1 Diabetes ◽  
Diabetic Ketoacidosis

'I have type 2, my brother has type 1, I can't hear you doctor! Metformin give me diarrhoea'

2020 ◽  
Author(s):  
Kyaw Linn ◽  
Zin Nwe Htut ◽  
Kamrudeen Mohammed
Sign in / Sign up

Export Citation Format

Share Document